Latest News

Title
Programme
Abstracts
Programme
14 Sep 2017 ESMO Press Release: ESMO announces new interim Editor-in-Chief of Annals of Oncology
Programme
14 Sep 2017 Reports on Care Quality for Adolescent and Young Adult Cancer Patients Are Lacking in the Literature Cancer in Special Situations
12 Sep 2017 ESMO 2017 Press Release: Best Poster at ESMO 2017 Shows Positive Trials Twice as Likely to be Reported in Lay Press
12 Sep 2017 ESMO 2017 Press Release: Best of ESMO 2017 Congress
12 Sep 2017 ESMO 2017: Daily Broadcasts
11 Sep 2017 ESMO 2017: Adjuvant Dabrafenib Plus Trametinib Significantly Lowers Risk of Death in Stage III BRAF V600–Mutated Melanoma Melanoma and other skin tumours - Anticancer agents & Biologic therapy
11 Sep 2017 ESMO 2017: Nivolumab Bests Ipilimumab as Adjuvant Therapy in Resected Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
11 Sep 2017 ESMO 2017: BRIM8 Data Shows Benefit with Adjuvant Vemurafenib in Resected BRAFV600 Positive Melanoma Melanoma and other skin tumours - Anticancer agents & Biologic therapy
11 Sep 2017 ESMO 2017 Press Release: Debate on Duration of Colon Cancer Adjuvant Chemotherapy Takes Centre Stage at ESMO 2017 Gastrointestinal cancers
11 Sep 2017 ESMO 2017 Press Release: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma Melanoma and other skin tumours
11 Sep 2017 ESMO 2017 Press Release: Adjuvant Nivolumab Superior to Ipilimumab in Surgically Resected Stage III/IV Melanoma Melanoma and other skin tumours